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Background: Par14, a member of the parvulin family of peptidyl-prolyl cis-trans isomerases that is involved in rRNA
processing, microtubule formation and the glucose metabolism and has been suggested to play a role in chromatin
remodeling on basis of sequence and structural identities to HMG proteins. Par14 is enriched in the nucleus and
binds to double-stranded DNA in vitro.
Results: By means of sub-nuclear biochemical fractionations, we demonstrate that cellular Par14 is associated with
chromatin 3-fold higher than with the nuclear matrix in vivo. Par14 is released from the chromatin fraction after
treatment with DNase I and elutes at high NaCl concentrations from the nucleic acid-binding fraction. Using
qRT-PCR and western blotting we demonstrate that Par14 is up-regulated during the S and G2/M phases in
synchronised human foreskin fibroblasts cells.
Conclusion: In the light of our results, Par14 can be described as an endogenous non-histone chromatin protein,
which binds DNA in vivo. We propose that Par14 is involved in a DNA-dependent activity such as transcription.
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The primary catalytic function of PPIases (EC 5.2.1.8) is
to accelerate cis-trans isomerization of Xaa-Pro peptide
bonds within polypeptide chains [1]. Hence, a role for
peptidyl-prolyl cis/trans isomerases (PPIases) in the
folding of newly synthesized proteins was inferred and
chaperone-like activity has been associated with several
PPIases [2,3]. There are few classes among the PPIase
family such as the cyclophilins (Cyps) [4], the FK506-
binding proteins (FKBPs) [5] and the prototyping Protein
phosphatase 2A (PP2A) phosphatase activator (PTPA)
[6,7]. Par14 and its isoform Par17 belong to a class of
PPIases called parvulins.
Both proteins are encoded by the gene PIN4 which is
located on chromosome Xq13.1 within the human gen-
ome [8]. The PIN4 promoter is TATA-less and situated
in a CpG island typical of housekeeping genes. Human
Par14 has a molecular weight of 14 kDa [9] and consists* Correspondence: peter.bayer@uni-due.de
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article, unless otherwise stated.of 131 amino acids. It was first cloned as a homologue
of human Pin1 and E. coli Par10 [10]. Par14 has an
N-terminal basic region (aa 1–35) and a C-terminal
PPIase domain (aa 36 – 131) [11,12]. Par17 is an elon-
gated isoform of Par14 that resulted by alternative tran-
scription initiation [8,13]. Whereas Par14 is already
present in metazoans, Par17 is only expressed in cells of
great apes, but not in those of other primates [14]. In
mammalian cells, the expression of Par14 was up-
regulated in heart and skeletal muscles [9,10].
Functional studies have shown that both Par14 and
Par17 are capable of accelerating the build-up of micro-
tubules [15]. Studies in HepG2 cells and mouse liver
revealed that Par14 associates with insulin receptor sub-
strate 1 (IRS-1) via its N-terminal residues, thereby enhan-
cing insulin-induced IRS-1 phosphorylation and affecting
glucose metabolism [16]. Immunocytochemistry studies
using a Par14 antibody have shown that endogenous pro-
tein is accumulated in the nucleoli of cells associating with
pre-ribosomal complexes [17]. From cellular fractionation
and mutational studies, Par14 showed an uneven distribu-
tion pattern between the cytosol and the nucleus fractionCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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cytoplasm.
Based on homologies and similarities of Par14 to mem-
bers of the High Mobility Group (HMG) of proteins [10]
and with structural features within the catalytic domain
similar to the transcription factor Lef-1 [14,18], double-
stranded DNA constructs were developed and tested for
their Par14 binding affinity in fluorescence titration,
DNA-cellulose binding and electro-mobility shift assays.
Par14 bound preferentially in a 100–400 nM range to bent
AT-rich DNA octamers in vitro. Such bent AT-rich seg-
ments of DNA are supposed to dictate nucleosome posi-
tioning [19] and play a role in transcription initiation.
Experiments with truncated Par14 showed that the un-
structured basic N-terminal part with sequence similarity
to the chromatin-unfolding domain of HMGN proteins
was indispensable for high affinity DNA binding. Subse-
quent experiments demonstrated that the phosphorylation
of Par14 on Ser19 regulated its sub-cellular localization to
the nucleus and its ability to bind DNA in vitro [20]. Mu-
tation of Ser19 to Ala abolishes phosphorylation and alters
the sub-cellular localization of Par14 from predominantly
nuclear to significantly cytoplasmic. Immunostaining
showed that a Glu19 mutant of Par14, which mimics the
phosphorylated state of Ser19, does not penetrate into the
nucleoplasm. As opposed to wild-type Par14, the in vitro
DNA binding affinity of the Glu19 mutant was stronglyFigure 1 Par14 localizes more to chromatin than to nuclear matrix. A
fractionation. B) Immunoblotting with the affinity-purified αPPIase, αMEK2,
fractions at a 1:1000 dilution. C) Distribution of Par14 in the various fraction
from three independent experiments were measured, normalized and the ba
version 3.1 was used.reduced, indicating that only the de-phosphorylated pro-
tein is active in DNA-binding in the cellular nucleus.
A considerable body of evidence supported the fact that
Par14 is a nuclear protein and binds to double stranded
DNA in vitro. In addition Par14 was reported in immuno-
fluorescence studies to accumulate around chromosomes
during mitosis [17]. Moreover, Pin1, a paralogous protein
to Par14, is a nuclear PPIase and it has been reported to
be involved in the regulation of the cell cycle. In the light
of these evidences, it was of paramount importance to in-
vestigate the sub-nuclear localization of Par14 by means
of biochemical fractionation and to investigate its re-
gulation within the cell cycle making use of cell cycle
synchronization deprivation and qRT-PCR.
Results
Par14 is a non-histone chromatin protein
A small-scale biochemical fractionation procedure of
an asynchronous culture of HeLa cells was performed
(Figure 1A). Subsequently, soluble cytosolic proteins (S1),
chromatin proteins with and without DNAseI (S2+/S2-)
and nuclear matrix proteins with and without DNAseI
(S3+/S3-) were isolated. Together with total cell extract
(TCE) and recombinant Par14 (rhPar14) these fractions
were run on a SDS-PAGE gel, which was further analyzed
by western blotting and densitometry (Figure 1B and C).
The band area signals for Par14 in the chromatin fractions) An asynchronous culture of HeLa cells was subjected to biochemical
αLamin B1 and αHistone H3 antisera to benchmark the different
s quantified by densitometric analysis. The area of the band signals
ckground signals were subtracted. Multi Gauge densitometry software
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those of the nuclear matrix fractions S3+ and S3-. The
densitogram shows the distribution of Par14 in the various
fractions (Figure 1C). From the Par14 band signal in S2+
(Figure 1B) it is deduced that Par14 was 1.4-fold released
from chromatin when treated with DNase I as opposed to
S2-, which did not undergo any nuclease treatment.
Hence, there is an enrichment of Par14 in the chromatin
fractions when compared to the nuclear matrix fractions.
Therefore, the differential release of Par14 from chromatin
after DNase I treatment, lends evidence to its intimate as-
sociation with DNA.
Par14 binds to DNA in vivo
In concert with our observation that Par14 associates
with chromatin and is released after treatment with
DNase I, it was mandatory to verify the in vivo binding
of Par14 to DNA using a different biochemical frac-
tionation approach. Qproteome nuclear subfractionation
kit from Qiagen (Germany) was used whereby nuclear
proteins are separated to allow for the detection of
low-abundance proteins such as transcription factors.
Fractions of cytosolic proteins (S1), nucleic-acid binding
proteins (E1-E3) and benzonase solubilized nuclei (S4+)
were isolated. Eluates were collected using increasing so-
dium salt concentrations (0.1, 0.35, and 1 M). Fraction S3
contained nucleic acid-binding proteins (Figure 2A) that
was later bound on a phospho-cellulose column. Fractions
S1, E1 - E3 eluted with 0.1, 035 and 1 M NaCl), S4+ to-
gether with TCE and rhPar14 were run on a SDS-PAGE
gel. Analysis of the eluates on an immunoblot showed that
at 0.35 M (E2) and 1 M (E3) Par14 was eluted (Figure 2B).
This finding demonstrated that Par14 was enriched in the
fraction that was known as nucleic acid-binding. Thus,
Par14 was bound to DNA when isolated from an en-
dogenous cellular environment. S4+ was the supernatant
of the nuclei pellet P4+ that was treated with benzonase,
and it was referred to as the solubilized nuclei fraction.
The presence of Par14 in S1 (cytosol) and S4+ (solubilized
nuclei) went to validate previously published data that
assigned Par14 to these compartments [20].
Par14 and polytene chromosomes
We have shown with ample credibility that Par14 is a
chromatin and non-histone protein, which binds to
DNA in vivo. Our next approach to validate this finding
was to investigate if Par14 in Drosophila melanogaster is
associated with chromosomes. Human Par14 (CCDS14417)
shares 72.5% sequence identity with its ortholog in Dros-
ophila melanogaster (CG11858-RA) and within their PPIase
domains, they share 81% sequence identity (Figure 3A).
Based on this fact, western blots were carried out using the
nuclear extracts (lanes 1 and 2) of Kc cells from Drosophila
melanogaster. A protein band of 14 kDa was detectedwhen the αPPIase was used and this band was absent
when the pre-immune antiserum of αPPIase was applied
(Figure 3B), proofing that the Par14 ortholog is associated
with polytene chromosomes. As we have now shown that
hPar14 binds to condensed and non-condensed DNA
in vitro and Par14 is phosphorylated by the casein kinase
2, a serine/threonine-directed kinase implicated in cell
cycle control [20], we wondered whether hPar14 might
undergo cell cycle correlated expression levels.
Par14 is up-regulated during the S and G2/M phases of
the cell cycle
The transcriptional regulation of Par14 across the cell
cycle was studied with the aid of qRT-PCR technology.
Human foreskin fibroblasts (HFF) were suitable for cell
cycle synchronization by serum deprivation. After 30–36
hrs of starvation by depriving cultured HFFs from FCS,
an aliquot of cells was obtained and termed G0 cells at
t = 0. The rest of the cells were re-stimulated to enter
the cell cycle. Aliquots of cells were collected within 14,
20, and 24 hrs after growth re-stimulation for G1, S and
G2/M cells respectively [21]. Cell cycle phases were de-
termined by DNA staining and fluorescence-activated
cell sorting (FACS) analysis. The distribution of the cells
relative to their location during the cell cycle can be
seen Figure 4A. Quantitative RT-PCR analyses were
done (Figure 4B) using primers for Par14 as previously
described [8]. U6 splisosomal RNA (U6 snRNA) was
used as an internal control [22] and transcription of cyc-
lin B2 served as a marker gene for the G2/M phase [23].
Transcriptional expression profiles for Par14 and cyclin
B2 were normalized against the expression profile for
snRNA U6. These results showed that Par14 is slightly
but significantly up-regulated 2- and 3-fold in the S and
G2/M phases of the cell cycle, respectively, where DNA
duplication and cell division takes place. To examine,
whether the observed transcriptional cell cycle depen-
dence of hPar14 is reflected on the protein level, we
additionally performed western blot studies followed by
subsequent densitometric analysis. Par14 is translation-
ally up-regulated within the G1, S and G2/M phases of
the cell cycle (Figure 4C) with respect to the G0 phase.
The protein shows a ~3-fold increase in G1 and ~4-fold
increase in both S and G2/M phases, respectively
(Figure 4D).
Discussion
It has been shown that Par14 is enriched in the nucleus
and that it has sequence and structural identities to
HMGB and HMGN proteins. The DNA and chromatin
association demonstrated in this study appear to be even
more plausible when combining these findings with the
functions of a series of recently discovered DNA-associated
Parvulin binding partners. ASCC2, a member of a novel
Figure 2 Par14 binds to DNA in vivo and elutes with increasing salt concentrations. A) An asynchronous culture of HeLa cells was subjected
to a biochemical fractionation of nuclear and nucleic acid binding proteins. B) Immunoblotting with the affinity-purified αPPIase, MEK2, and nuclear
matrix protein p84 antisera to benchmark the different fractions at 1:1000 dilution.
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to interact with PIN4 in a yeast two-hybrid screening [25].
In the same assay, polycomb group (PcG) protein EZH2
(Enhancer of Zeste homologue 2), a histone methyltrans-
ferase associated with transcriptional repression, was re-
ported as an interactor to PIN4. Fujiyama and colleagues
demonstrated that nucleolin interacted with Par14 [17,26].
In co-immunoprecipitation experiments, Rickards and
co-authors confirmed nucleolin to be associated with
chromatin-containing rRNA genes transcribed by RNA
polymerase I only [27]. They proposed that the function
of nucleolin is to permit the transcription of nucleolar
chromatin by RNA polymerase I. Furthermore, nucleolinwas reported as a nuclear protein with a histone cha-
perone function [28]. Its histone chaperone activity en-
hanced the activity of chromatin remodeling machineries
such as SWI/SNF and ACF. With these several lines of
evidence shown, we postulate that Par14 is involved in
transcriptional regulation and/or chromatin remodeling
based on its association to chromatin.
Beside Par14 other proline isomerases have also been
shown to be associated with chromatin. The nuclear
FKBP, SpFkbp39p from Schizosaccharomyces pombe was
reported to be a histone chaperone regulating rDNA
silencing and it influenced chromatin organization both
in vivo and in vitro [29]. Still in yeast, Fpr4, a member of
Figure 3 Par14 is found on the nuclear extracts of Drosophila melanogaster. A) Sequence alignment of human Par14 with that of Drosophila
melanogaster. Identical residues are shown in blue. Multiple sequence alignment with the Clustal series of programs was used B) Immunoblots of
nuclear extracts from Drosophila melanogaster Kc cells, recombinant Par14 (rhPar14) and Total Cell Extract (TCE). Lanes 1 and 2: nuclear extract from
Drosophila melanogaster Kc cells; Lanes 3 and 4: rhPar14 and TCE. A band of 14 kDa is observed on lanes 2, 3 and 4 and not on lane 1 that
corresponded to the molecular weight of Par14.
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bind the amino-terminal tail of histones H3 and H4 and
catalyzes the isomerization of histone H3 proline P30
and P38 in vitro [30]. In the same work, they also
showed that the abrogation of Fpr4 catalytic activity
in vivo resulted in increasing levels of H3K36 methyla-
tion and delayed transcriptional induction kinetics of
yeast-specific genes. The work summarizes proline isom-
erization as a novel non-covalent histone modification
that regulates transcription and provides evidence for
crosstalk between histone lysine methylation and proline
isomerization. Above all, Pin1 and its ortholog Ess1,
have been demonstrated to modulate the C-terminal do-
main (CTD) of RNA polymerase II (Pol II) during the
transcriptional cycle [31,32]. The CTD is the largest
subunit of Pol II and contains repeatedly the heptad se-
quence (Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7) that plays
a key role in the transcription cycle, coordinating the ex-
change of transcription and RNA processing factors.
CTD exhibits several structurally flexible heptapeptide
repeats that undergo conformational changes in the ad-
vent of serine phosphorylation and proline isomerization
by Pin1/Ess1, which then have an effect on the transcrip-
tion of genes. The up-regulation of Par14 in the S and
G2/M Phases of the cell cycle in concert with its DNAand chromatin association might be a hint that Par14
also acts on the transcriptional regulation of genes.
Conclusion
To obtain valuable clues for its cellular function it was
of paramount importance to investigate the sub-nuclear
localization of Par14. The performed analysis of the nu-
clear fraction separating chromatin and nuclear matrix
proteins ascertains that Par14 is a non-histone protein
associated with chromatin. Previous studies from DNA-
cellulose binding assays and EMSA have demonstrated
that Par14 binds to DNA in vitro. Our results from the
fractionation of nuclear and nucleic acid-binding pro-
teins strengthen the contention that Par14 binds to
DNA in vivo. In addition Par14 was reported in im-
munofluorescence studies to accumulate around chro-
mosomes during mitosis. We have now demonstrated
that Par14’s ortholog in Drosophila melanogaster is asso-
ciated with the polytene chromosomes and that hPar14
can be collected from a chromatin protein fraction in
human cells. The transcriptional and translational up-
regulation of Par14 in the S and G2/M phases of the cell
cycle and the dependence of its DNA binding properties
on the phosphorylation by the casein kinase 2 relates the
action of Par14 to cell cycle regulation and/or DNA
Figure 4 Up-regulation of Par14 in the S and G2/M phases. A) Percentage cell cycle distribution. Human foreskin fibroblasts (HFF) were
examined by DNA staining with propidium iodide followed by FACS analysis. Numbers denote percentage of cells in G0, G1, S and G2/M phase.
Percentage of cells at G0 was fixed to 100 after serum deprivation. The arithmetic mean (X-mean), is an indicator of the fluorescence intensity i.e.
the number of propidium iodide molecules bound to DNA. A value above 200 is considered as appropriate. The results show the average of five
independent cell cycle synchronisation experiments. For each sample, 1 × 104 cells were analysed B) qRT-PCR analysis of Par14 across the cell
cycle with synchronised HFF. White columns represent the percentage mRNA expression, dark blue columns the percentage mRNA expression of
cyclin B2. After 30–36 hrs of serum deprivation, cells in G0 were arrested at t = 0 h. HFF cells were re-stimulated with 20% FCS. G1 cells were
harvested after t = 14 h, S phase cells after t = 20 h and G2/M cells after t = 24 hrs. mRNA levels of Par14 were normalised using snRNA U6.
One-way ANOVA was performed using R. The bars represent the standard deviation from five independent cell cycle synchronisation and
qRT-PCR experiments conducted. The asterisks on the bars indicate the statistical significance expressed in p-values (** = p≤ 0.01; * = p≤ 0.05).
C) Translational up-regulation of protein across the cell cycle. Western blot analysis was done using αPPIase (1:1000) and β- actin (1:5000) antisera.
30 μg of protein for each cell lysate from the respective phase of the cell cycle was loaded. D) Densitometric analysis from three independent cell
cycle synchronisation and western blot experiments of Par14 protein. Band signals were normalised with β- actin.
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ation and the homologies of structural motifs of Par14
to those of the transcription factor Lef-1 these findings
suggest that Par14 parallels in part the cellular function
of its paralog Pin1, but is acting on non-phosphorylated
epitopes of its target proteins.
Methods
RNA extraction and RT-PCR analysis
Extraction of total RNA from human foreskin fibroblasts
(HFF) cells was performed with TRIzol Reagent (Invitro-
gen, Germany) according to the supplier’s instructions.
Real-time RT-PCR mRNA-quantification was done with
the LightCycler system (Roche, Germany). Primers for
Par14 5′ to 3′ were: 253-TGG GAG TGA CAG TGC
TGA CAA and 254- CAT GTT TTT CAC ATA GAA
TGT GTC TGA C [8]. Expression of U6 snRNA (GenBank
NR_004394) was used as an internal control constant
during the cell cycle with the following primers: forward:
CTC GCT TCG GCA GCA CA and reverse: AAC GCT
TCA CGA ATT TGC GT. As a positive control, expres-
sion of the cell cycle regulating protein Cyclin B2-gene
was measured [23]. Cyclin B2-mRNA was detected with
the following primers: forward: AAA GTT GGC TCC
AAA GGG TCC TT, reverse: GAA ACT GGC TGA ACCTGT AAA AAT. Relative expression changes were calcu-
lated using the 2-ΔΔCT method [33,34]. All PCR-products
used in the LightCycler mRNA quantifications were con-
firmed by sequencing to check their identity.Eukaryotic cell culture
HeLa cells (DSMZ, Germany) were cultured in growth
medium (D-MEM, 1% MEM, 10% heat-inactivated fetal calf
serum and 1% penicillin/streptomycin; Gibco, Germany) in
T-75 cm2 culture flasks (Greiner, Frickenhausen) and in-
cubated at 37°C in a 5% CO2 incubator. HFF cells were
also grown in the same culture medium like HeLa cells
but devoid of 1% MEM. Cells were allowed to grow to
80 - 90% confluence and were sub-cultured as follows:
culture medium was discarded and cells were washed
briefly two times with pre-warmed PBS, pH 7.4. There-
after, cells were trypsinized with 1 ml Tryple Express per
flask (Gibco, Germany) and incubated for 3 min at 37°C
and 5% CO2. Cell detachment from the culture flasks with
Tryple Express was halted by adding 10 ml of culture
medium and the cell suspension was transferred to a
15 ml centrifuge tube. Centrifugation was done for 5 min
at 200 × g and the cell pellet was re-suspended in 3–5 ml
culture medium.
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HFF cultures were synchronized by serum deprivation.
Cells were arrested in the G0 phase before re-entry into
the cell cycle [35,36]. 1.5 × 106 HFFs were seeded and
allowed to grow to about 65% confluence in culture
medium (D-MEM 10% foetal calf serum and 1% Pen/
Strep; Gibco, Germany) in a T-300 cm2 culture flask
(TPP, Germany) at 37°C and 5% CO2. The medium was
aspirated and the cells were thoroughly washed 3 times
with pre-warmed PBS, pH 7.4 to remove any trace of
serum. After 30–36 hrs of starvation by depriving cul-
tured HFFs from FCS. The rest of the cells were further
cultured in medium containing 20% FCS to re-stimulate
them to enter the cell cycle. Aliquots of 1.3 × 107 cells
were collected within 14, 20, and 24 hrs after growth re-
stimulation for G1, S and G2/M cells respectively [21].
No cell cycle synchronization method is known to date,
which achieves a 100% distribution of cells into the re-
spective phases.Fixation
Cells gained from the different phases of the cell cycle
were permeabilized for intracellular staining. 1 × 105
HFF cells from each phase of the cell cycle were re-
suspended in 200 μl PBS, pH 7.4. 200 μl of ice-cold 70%
ethanol was added drop wise to the cells under gentle
agitation (750 rpm) in a thermormixer and incubated
for 15 – 60 min at 4°C. The cells were pelleted at 750 ×
g for 4 min at RT. Respective pellets were washed with
PBS; pH 7.4 supplemented with 1% fetal bovine serum
(FBS) and allowed to equilibrate for 20 min at RT while
rocking on a shaker. Cells were centrifuged in a swing
bucket centrifuge at 1800 × g for 5 min. As a technical
hint, a fixed-radius centrifuge will not pellet the cells at
this step even at high centrifugal forces. The pelleted
cells were ready for use or were stored at −20°C until
use.Propidium iodide staining and flow cytometry analyses
Before staining with propidium iodide, aliquots of the
fixed cells were washed once with PBS, pH 7.4 and re-
suspended in 750 μl PBS. After treatment of the cells with
10 μl of 50 μg/ml RNase (Sigma-Aldrich, Germany) for
30 min under gentle agitation with a thermomixer at
37°C. 15 μl of 50 μg/ml propidium iodide (Roth, Germany)
were added to the cells and incubated for 5 min making
them ready for fluorescence activated cell sorting (FACS)
analysis. FACSCalibur flow cytometer (Becton Dickson
Science, Germany) was used. Data processing was
done with the software CellQuest™ Pro (Becton Dickson
Science, Germany). For each sample, 1 × 104 cells were
analyzed.Production and affinity purification of anti-serum against
the PPIase domain of Par14 (αPPIase)
To generate αPPIase polyclonal antibodies, amino acids
36–131 corresponding to the PPIase domain of full length
Par14 was cloned into the expression vector pET-41 ac-
cording to standard procedures, which has been modified
with PreScission protease restriction sites [37]. For protein
production, the plasmid was over-expressed in Escherichia
coli strain BL21 (DE3) and purified as a glutathione
S-transferase (GST) fusion protein. A total of 2 mg of the
recombinant PPIase was sent for immunization of a rabbit
(Eurogenetec, Belgium) and western blots were per-
formed to analyse the test bleeds. The final antiserum
αPPIase was purified by affinity chromatography using a
CNBr-activated Sepharose 4 fast Flow (GE Healthcare,
Germany). The purified antibody was used for all western
blots conducted to detect both endo- and exogenous
Par14.
Sub-nuclear fractionation
Procedures for solubilization and sequential small-scale
biochemical sub-nuclear fractionation were adapted from
the method of [38]. In summary, 4 × 107 HeLa cells were
harvested by using a cell scraper and spun at 200 × g for
2 min and the supernatant was discarded. The pellet was
washed two times with PBS, pH 7.4 and spun down at
200 × g for 2 min. The re-suspension and sulubilization of
the pellet was done in 5 ml low salt lysis buffer (10 mM
HEPES, pH 7.4, 10 mM KCl, 0.1% Triton X-100) sup-
plemented with a cocktail of protease inhibitors (Roche
Diagnostics, Germany) and 1 mM PMSF for 15 min at 4°C.
The solubilized nuclei pellet (P1) was recovered at 200 × g,
5 min at 4°C and the supernatant collected was termed
the cytosolic fraction, S1 (Figure 2A). P1 was washed again
three times with low salt lysis buffer to remove any cyto-
plasmic contaminants and centrifugation was done like
above. The nuclei pellet was re-suspended in 800 μl lysis
buffer and separated in two equal volumes of 400 μl and
termed P1- and P1+ respectively. Incubation of P1- on ice
was done for 30 min. At the same time, P1+ was treated
with 30 U DNase I (RNase free, New England BioLabs,
Germany) and incubated for 15 min at RT and later for an
extra 15 min at 37°C. DNase I in P1+ was inactivated for
10 min at 75°C. Chromatin proteins were extracted from
P1- and P1+ by adding 500 μl of extraction buffer (1%
Triton X-100, 50 mM HEPES, pH 7.4; 150 mM NaCl,
30 mM Na4P2O7 · 10 H2O, 10 mM NaF, 1 mM EDTA) con-
taining a cocktail of protease inhibitors (Roche Diagnostics,
Germany) and 1 mM PMSF, for 15 min at 4°C res-
pectively. Both P1-/P1+ were centrifuged at 14,000 × g for
10 min at 4°C and the respective supernatants S2-/S2+
were collected and named chromatin fractions. The
resulting pellets P2-/P2+ were solubilized in 250 μl urea
buffer (8 M urea, 100 mM NaH2PO4, and 10 mM Tris–
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in a micro-centrifuge for 10 min at 4°C. The supernatants
S3- and S3+ collected respectively were named nuclear
matrix fractions.
Fractionation of nuclear and nucleic acid binding proteins
Qproteome nuclear subfractionation kit (Qiagen, Germany)
was used for the fractionation procedure and the extrac-
tion of nucleic acid binding proteins. The manufacturer’s
protocol was used and the scheme of the procedure is
illustrated in (Figure 3A). A phosphor-cellulose column
provided in the kit was used for the elution of nucleic acid
binding proteins. The eluates E1, E2 and E3 were concen-
trated and desalted by chloroform/methanol precipitation
[39]. Bradford assay was used to determine the concentra-
tions of S1, E1, E2, E3 and S4+ and equal amount of pro-
tein from the fractions was loaded for electrophoresis and
subsequent western blotting analyses.
SDS-PAGE and immunoblotting
SDS-PAGE and immunoblotting were carried out ac-
cording to standard protocols with the following nota-
tions. After determining the protein concentrations by
the Bradford method, 30 μg protein per lane except
otherwise stated were resolved on 12.5 or 15% SDS-
PAGE gels [40]. Electrophoretic separation was carried
out for about 2 hrs at 125 V in a Novex MiniCell Chamber
(Invitrogen, Germany). Blotting was done on a nitrocellu-
lose membrane (Invitrogen, Germany) in transfer buffer
(25 mM Tris–HCl, pH 8.0 – 8.3, 192 mM glycine, 20%
methanol) at 30 V for 1 hr using the semi-dry Fastblot
apparatus (Biometra, Germany). Immunoreactions on
the membranes were visualized with the use of an en-
hanced chemiluminescence (ECL western blot reagents)
kit followed by exposure on CL-XPosure Film (Thermo
Scientific, Germany). Protein bands on the film were
developed using the AGFA Curix 60 developer (AGFA,
Germany).Determination of Par14 protein expression
Total Cell Lysates (TCE) were obtained from HFF cul-
tures synchronized by serum deprivation and processed
for immunoblotting as described above. Normalisation
of Par14 expression was done with β-actin. Firstly, the
expression of β-actin at G0 was obtained by dividing the
value of its band signal area by its self and a factor of 1
was obtained. This was done because we considered
cells at G0 to be resting and thus no relative expression
changes. Secondly, the relative expression of β-actin at
G1, S and G2/M phases was calculated with respect to
its expression at G0. This was done by dividing the
values of the respective band signal areas at G1, S and
G2/M by the value of the band signal area at G0. Thiscan be explained by the following equation for the rela-
tive expression at G1:
Relative Expression of β-actin at G1 = (Band signal
area at G1 – Background signal)/(Band signal area at
G0 – Background signal)
Normalisation of Par14 expression in the various
phases of the cell cycle was derived by dividing the value
of the band signal area of Par14 at the phase in question
by the relative expression of β-actin during this phase:
Normalisation of Par14 at G1 = (Band signal area of
Par14 at G1- Background signal)/(Relative expression of
β-actin at G1)
Fold changes of Par14 at G1, S and G2/M were done
by dividing the normalised value of Par14 at the respec-
tive phase by its normalised value at G0:
Relative expression of Par14 at G1 = (Normalised value
of Par14 at G1)/(Normalised value of Par14 at G0)
Calculations for the S and G2/M phases were done in
the same manner. The results in Figure 4D were obtained
from three independent and averaged experiments.
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